Does KARDEGIC Cause Interstitial lung disease? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Interstitial lung disease have been filed in association with KARDEGIC. This represents 4.0% of all adverse event reports for KARDEGIC.
6
Reports of Interstitial lung disease with KARDEGIC
4.0%
of all KARDEGIC reports
1
Deaths
6
Hospitalizations
How Dangerous Is Interstitial lung disease From KARDEGIC?
Of the 6 reports, 1 (16.7%) resulted in death, 6 (100.0%) required hospitalization.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for KARDEGIC. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does KARDEGIC Cause?
Anaemia (18)
Haematoma (16)
Melaena (9)
Drug interaction (7)
International normalised ratio increased (7)
Diarrhoea (6)
Fall (6)
Gastrointestinal haemorrhage (6)
Pancreatitis acute (6)
Subdural haematoma (6)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which KARDEGIC Alternatives Have Lower Interstitial lung disease Risk?
KARDEGIC vs KEPPRA
KARDEGIC vs KETAMINE
KARDEGIC vs KETOCONAZOLE
KARDEGIC vs KETOPROFEN
KARDEGIC vs KETOPROFEN LYSINE